In breast cancer cell lines, Mittendorf et al showed that PTEN loss resulted in overexpression of PD‐1 and PD‐L1 which was downregulated after PI3K pathway inhibition and may increase antitumor adaptive processes.41 The gene discussed is PIK3CA; the disease is breast cancer.